New Condition proposed as Sluggish Cognitive Tempo - Eli Lilly

The Journal of Abnormal Child Psychology devoted 136 pages of its January issue to papers describing the new condition called Sluggish Cognitive Tempo, with the lead paper claiming that the question of its existence �seems to be laid to rest as of this issue.� Russell Barkley of the Medical University of South Carolina, for 30 years one of ADHD�s most influential proponents, has claimed in research papers and lectures that Sluggish Cognitive Tempo �has become the new attention disorder.�

A clinical trial funded by Eli Lilly investigated whether proposed symptoms of Sluggish Cognitive Tempo could be treated with Strattera, the company�s primary ADHD drug. (It is not a stimulant like Adderall and Concerta which medications more susceptible to abuse). His study, published in The Journal of Child and Adolescent Psychopharmacology, concluded, �This is the first study to report significant effects of any medication on SCT.

ADHD which despite having hyperactivity in its name includes about two million children who are not hyperactive, merely inattentive. Some researchers propose that about half of those children would be better classified as having Sluggish Cognitive Tempo.